Diagnosis of multiple osteomas in an ancient skeleton discovered in the necropolis of Caravate - Northern Italy
Keywords:
multiple osteomas, Gardner’s Syndrome, X-ray, Computer tomography, Caravate, ItalyAbstract
Background and aim of the work: A great number of neoplastic lesions are reported in paleopathological literature, in different periods and geographic areas; this is a proof that numerous tumors affected past populations. In particular, osteoma is a lesion that is familiar to paleopathologists. Nevertheless, the presence of multiple osteomas is poorly documented in paleopathological records. The aim of this paper is to report a pathological condition of multiple osteomas found in an ancient skull unearthed in the medieval necropolis of Caravate (Varese-North Italy). Methods: The classical physical anthropological methods were used for the macroscopical identification (race, sex, age at death and stature) of all the skeletons recovered by archaeologists. Biological identification of the skeleton followed guidelines recommended in Buikstra & Ubelaker (1994). Results: Radiological exams allowed to discover compact dense and uniform areas of thickening in the skull of Tomb 1, normally associated with Gardner’s Syndrome. The characteristic of this illness is the advancement of hundreds to thousands of intestinal adenomas (familial adenomatous polyposis, FAP), which can cause the development of colon or intestinal cancer. Conclusions: Paleopathology documented that benign and malignant tumors were present since the Neolithic. The scarcity of paleopathological cases of multiple osteomas reveals the necessity for more extensive research on paleoncology, through the systematic analysis on human osteological collections. To better understand possible case of Gardner's Syndrome, it would be useful to extend the analyses to all other skulls from the skeletal remains of the necropolis.Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.